Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 9, 2025

New York man wants to borrow from 401(k) to pay $33K debt. Dave Ramsey is against it, but here's when it makes sense

View original at finance.yahoo.com
New York man wants to borrow from 401(k) to pay $33K debt. Dave Ramsey is against it, but here's when it makes sense The Ramsey Show Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • OfficialHomeInsurance.com can save users an average of $482

    80% confidence
  • At the end of 2024, 13% of 401(k) plan participants had an outstanding loan against their balance

    80% confidence
  • The goal is to get people out of debt so they can build wealth, change their family tree, and be outrageously generous

    80% confidence
  • Nearly 50% of Americans are making one big Social Security mistake

    80% confidence
  • The average 401(k) loan amount is $11,067

    80% confidence
  • Dave should spend the next 12 months paying only for essentials and put the rest of his paycheck toward debt

    80% confidence
  • Dave should stop saving and investing until he's debt-free

    80% confidence
  • Dave should get on a budget and clean up his debt mess instead of trying to find a hack

    80% confidence
  • One asset will surge 400% in a year

    80% confidence
  • The average credit card APR is 22.83%

    80% confidence
  • The average U.S. consumer pays $1,237 in monthly debt across their various obligations

    80% confidence
  • If you leave your employer, you would have to repay your 401(k) loan in full in a short time frame

    80% confidence
  • Median weekly earnings for American workers were $1,196 during the second quarter of 2025

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com